Table 2.
Selected target genes
Category | Target |
---|---|
ampC resistances | ACC; ACT/MIR; ampC; BIL/LAT/CMY; DHA; FOX; MOX/CMY |
Carbapenem resistance | IMP-1 group; IMP-16; IMP-2 group; IMP-7; KPC; NDM; OXA-23; OXA-40; OXA-48; OXA-58; OXA-72; VIM |
Extended-spectrum beta-lactamase | CTX-M group 1; CTX-M group 2; CTX-M group 8/25; CTX-M group 9; GES; OXA-1; PER-1; PER-2; SHV; TEM; VEB |
Macrolide resistance | ErmA; ErmB, mefE |
Quinolone and fluoroquinolone resistance | QnrA; QnrB |
Vancomycin resistance | vanA1; vanA2; vanB; vanC1; vanC2-C3-1; vanC2-C3-2 |
Endogenous control | 16S (bacterial); GAPDH (human) |
Inhibition control, exogenous | exoIPC |
Species-specific genes | ACICU_00593 (Acinetobacter baumannii); femA SA (Staphylococcus aureus); femA SE (Staphylococcus epidermidis) |